Loading organizations...
§ Private Profile · Bethany, CT, USA
Medical device company developing the Corisma MCS Pump for advanced heart failure patients, focused on fully implanted trans catheter systems.
Founded in 2020 by Yale New Haven Hospital cardiac surgeon Pramod Bonde, Corisma is a medical device company based in Hamden, Connecticut, currently led by Chief Executive Officer Mark Oliver. The organization's primary product is the fully implanted Corisma MCS Pump, a transcatheter system designed to eliminate drivelines and reduce infection risks without requiring open-heart surgery. The core technology was originally spun out from the Bonde Artificial Heart Lab at Yale University, leveraging specialized research on wireless energy transmission to improve patient quality of life. Operating with fewer than twenty-five employees, the venture-funded business currently generates under five million dollars in estimated annual revenue as it develops these innovative heart failure systems. This medtech startup ultimately aims to redefine mechanical circulatory support for patients suffering from advanced heart failure within the medical technology sector.
Corisma has raised $27.0M across 1 funding round.
Corisma has raised $27.0M in total across 1 funding round.
Corisma has raised $27.0M across 1 funding round. Most recently, it raised $27.0M Series A in August 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 31, 2021 | $27M Series A | Grand Pharmaceutical Group | — | Announced |
Corisma has raised $27.0M in total across 1 funding round.
Corisma's investors include Grand Pharmaceutical Group.